The executive team at Epsilogen has experience in managing partner at Longcross Advisers, LLP, being a principal at Torreya Partners, and head of healthcare research at Pacific Growth Equities, as well as a senior principal at Atlas Venture. The team members have a variety of educational backgrounds, including molecular biology from the University of Cambridge and biochemistry from Imperial College London.
View all